Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Liabilities from Discontinued Operations (2020 - 2021)

Palisade Bio (PALI) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 219757.0 as the latest value for Q1 2021.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 219757.0 in Q1 2021 year-over-year; TTM through Mar 2021 was 219757.0, a N/A change, with the full-year FY2020 number at 234344.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations was 219757.0 for Q1 2021 at Palisade Bio, down from 234344.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 325812.0 in Q3 2020 to a low of 219757.0 in Q1 2021.